5 Ways You Can Get More Xarelto Lawsuit While Spending Less

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning hard to obtain these hurt by the drug the compensation they are entitled to.

Whilst bleeding is a typical complication associated with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, within the event of an emergency, sufferers might be at danger for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved one suffered a critical bleeding occasion soon after taking Xarelto, you may have legal recourse. For far more data, make contact with us right now to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in circumstances of death, funeral costs. Furthermore, they're in search of punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for a lot more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed click through the next site multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.